Earnings Feed
Start Free
Lineage Cell Therapeutics, Inc.·4

Jun 23, 1:15 PM ET

KINGSLEY ALFRED D 4

4 · Lineage Cell Therapeutics, Inc. · Filed Jun 23, 2021

Insider Transaction Report

Form 4
Period: 2021-06-22
Lineage Cell Therapeutics, Inc.LCTX
KINGSLEY ALFRED D
10% Owner
Transactions
  • Exercise/Conversion

    Common Shares, no par value

    2021-06-22$2.20/sh+61,800$135,960→ 5,470,245 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-06-22−61,800→ 0 total
    Exercise: $2.20Exp: 2021-06-30→ Common Shares (61,800 underlying)
Holdings

  • Common Shares, no par value

    (indirect: By corporation)
    1,043,346

  • Common Shares, no par value

    (indirect: By LP)
    375,351
Footnotes (3)
  • [F1]Held by Greenbelt Corporation, of which Mr. Kingsley is an executive officer, director, and controlling shareholder. Mr. Kingsley disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest.
  • [F2]Held by Greenway Partners, LP, of which Mr. Kingsley is the General Partner and has sole voting and dispositive control.
  • [F3]This option became exercisable in four equal quarterly installments after the date of grant on July 1, 2016.

Documents

2 files